Bespak is a global contract development and manufacturing organisation (CDMO) focused on inhaled and nasal drug delivery devices and drug-device combination products. Bespak develops and manufactures finished pharmaceutical products, as well as being a leading global supplier of drug delivery devices and componentry to the pharmaceutical industry.
With a long history in the development and commercial supply of pressurised Metered Dose Inhalers (pMDIs), Bespak supplies a major proportion of the world’s pMDI dosing valves and actuators, and also specialises in the industrialisation and high-volume manufacture of complex dry powder inhaler (DPI) devices.
Headquartered in Holmes Chapel, UK, the company’s service offering spans early-stage feasibility, analytical and product development, through pilot-scale, clinical and commercial-scale drug product fill-finish, to device and component manufacturing.
Bespak
London Road
Holmes Chapel, Cheshire CW4 8BE
United Kingdom
+44 (0)1477 537 112
bespak.com/
enquiries@bespak.com
Inhaled and Nasal Drug Delivery
A full-service partner for inhaled and nasal drug delivery. Built on decades of experience designing, developing and manufacturing pulmonary and nasal drug delivery devices, and drug-device combination products, for local and systemic applications. More Info
Your complete partner for pMDIs
Three sites, one seamless service for pMDI product development through to commercial supply:
Bespak North Carolina – with over 20 years of experience developing and testing orally inhaled and nasal drug products.
Bespak King’s Lynn – a leader in pMDI valves globally, with complementary expertise in actuators and dose counters.
Bespak Holmes Chapel – with 60 years of experience manufacturing orally inhaled drug and nasal drug products.
More Info
Leading the transition to low GWP pMDIs
Climate-friendly propellants are vital to lowering our industry’s environmental footprint. We’re not only developing compatible formulations and devices, but have committed to commercial-scale manufacturing with both low GWP propellants HFA-152a and HFO-1234ze by as early as 2025. More Info
Unit Dose Nasal Spray – NasaDose™
Our novel customisable intranasal unit dose drug delivery platform offers unique performance advantages, ensuring consistent dosing and spray performance. Patented spring-powered mechanism offers ease-of-use for patients, their caregivers and healthcare professionals. More Info
Resyca® Soft Mist Inhalers
Resyca® is a joint venture between Bespak and Medspray and specialises in the development and manufacturing of compact, user-friendly soft mist inhalation and soft nasal spray devices, incorporating the proprietary Medspray spray technology. These devices are tailored for pulmonary and nasal applications and utilise low shear force technology ideally suited to the delivery of complex or fragile biologics. More Info
Device Contract Manufacturing
We pride ourselves on delivering manufacturing excellence for inhalation devices, from Design for Manufacture through to scale-up and into commercial supply. With our experienced workforce and dedicated cleanrooms, we are trusted by the world’s leading respiratory companies to manufacture their complex devices as a solus or secondary source of supply. More Info
